Type 2 diabetes mellitus has a positive role in osteomyelitis: A Mendelian randomization analysis

Ma Fu,Han Qi,Suyue Zhu,Dongsheng Zhu,Chao Sun

DOI: https://doi.org/10.1097/md.0000000000039833

IF: 1.6

2024-09-29

Medicine

Abstract:Osteomyelitis (OM), a bone inflammation caused by infectious disease, is a notoriously challenging condition to treat. It often leads to severe soft tissue damage, bony abnormalities, and ultimately nonunion. [ 1 ] Localized redness, swelling, suppuration, and pain are common early clinical indicators of OM, although their specificity is limited and the initial features can be ambiguous. [ 2 ] Localized redness, swelling, suppuration, and pain are common early clinical indicators of OM, although their specificity is limited and the initial features can be ambiguous. [ 3 ] Type 2 diabetes (T2D) is a prevalent chronic disease worldwide, with an estimated prevalence ranging from 7.4% to 12.8%, which has been steadily increasing over the years. [ 4 ] Key risk factors for T2D include obesity, physical inactivity, unhealthy dietary habits, and genetic predisposition. [ 5 ] Common complications associated with T2D include cardiovascular disease, nephropathy, retinopathy, and neuropathy, OM, significantly impacting patients' quality of life. [ 6 ] Insulin resistance and dysfunctional insulin secretion are key characteristics of T2D. Recent research has identified several contributing factors to the pathophysiology of T2D, including endoplasmic reticulum stress, mitochondrial dysfunction, oxidative stress, glucose toxicity, and lipid toxicity. [ 7 ] Moreover, the link between diabetes-induced OM is becoming more prevalent and has garnered increased attention. [ 8 ] Albright first suggested this connection in 1966. [ 9 ] While there is growing evidence that T2D plays a crucial role in the development of OM, a causal relationship between the 2 conditions has yet to be established.

medicine, general & internal